Table 1.

Patient characteristics.

Characteristic	rhC1-INH (N = 71)
Sex, n (%)
Male	30 (42.2)
Female	41 (57.7)
Race, n (%)
White	71 (100)
Age at HAE diagnosis, y mean (range)	27 (3–70)
Age, y, mean (range)	47.3 (19–78)
Number of yearly attacks before enrollment
Mean	25
Median	16
Range	0–185
Receiving prophylaxis/maintenance therapy at enrollment, n (%)	20 (28.2)
Body weight, kg, mean	78.3

HAE: hereditary angioedema, rhC1-INH: recombinant human C1-esteraseinhibitor.